Who Paid My Doc
A Phase 4, Open-Label, Single Arm Study to Optimize Implementation of
Research payments
$221,079
Through program year 2024, $221,079 in research payments was reported against A Phase 4, Open-Label, Single Arm Study to Optimize Implementation of, across 166 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $77,761 | 46 |
| 2023 | Research | $130,294 | 109 |
| 2022 | Research | $13,024 | 11 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Khan Nedd Grand Rapids, MI Named on 81 payments
- Indigo Dillard Benbrook, TX Named on 26 payments
- Kevin Summers Pasadena, TX Named on 17 payments
- Jason Raasch Greenfield, WI Named on 14 payments
- Beth Bingaman Raleigh, NC Named on 10 payments
- Roxana Ropos North Richland Hills, TX Named on 9 payments
- Christine Smith Liberty, MO Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.